Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Read the MDA for Q1 2020
View:
Post by sah1 on May 14, 2020 10:41am

Read the MDA for Q1 2020

On Sedar. It is very sobering.
Comment by ualcin1 on May 14, 2020 11:33am
sah1, can you expand?
Comment by aussyspitz on May 14, 2020 11:42am
Look at Gobb's prior post here is why it is sobering: we are currently unable to predict the timing of our BLA resubmission. Further, it is possible that when we submit, we could experience delays in the timing of review and/or our interactions with FDA due to, for example, absenteeism by governmental employees, inability to conduct planned physical inspections related to regulatory approval, ...more  
Comment by sah1 on May 14, 2020 11:47am
The likely need for successive financings is also very sobering!
Comment by foofadooo on May 14, 2020 11:57am
They figured 12 months....hopefully something from FDA before then ....it seems a bit of political lag may be at play. Covid could turn into a catapult but that hinted at price and cost...a bit of  a Mexican Stand off without compassionate use. foof
Comment by ualcin1 on May 14, 2020 12:09pm
sah1: am I to take it that you're expecting another dilution?
Comment by sah1 on May 14, 2020 3:00pm
Ualcin,  I am just repeating words that I read in the MDA.  Covid is a curse on humanity but also small  busiesses including Lmnl. Galbraith said that the company had run the new quality control system successfully for 6 months. This suggests That Bla submission is ready and would be successful and approved in due course. But this can’t happen in the near term nor can the marketing ...more  
Comment by GunnerG on May 14, 2020 3:37pm
"This suggests That BLA submission is ready".  I could not find in the MDA this quote.  Please explain why they don't submit the paperwork then if its ready?  Nine months since processes completed. Sah you have been wrong so many times; under the old management and new management.   "and approved in due course" , exactly the suggestions you were ...more  
Comment by GunnerG on Jun 12, 2020 11:31pm
This posted one month ago and still nothing.  You guys just keep making up BS.
Comment by ualcin1 on May 14, 2020 8:33pm
Thanks sah1
Comment by aussyspitz on May 14, 2020 12:32pm
Agreed
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities